# TELA Bio (TELA) — Earnings

TELA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tela/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.20 |
| EPS estimate | −$0.17 |
| EPS surprise | −15.14% |
| Revenue surprise | −3.59% |
| Revenue | $19.3M |
| Revenue estimate | $20.0M |
| Reported | Aug 10, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1561921/000110465926094039/tela-20260630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/1a609fc9-2bb0-d576-e1e1-3d61e79b05d7.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 10, 2026 | −$0.17 | −$0.20 | -15.14% | $20.0M | $19.3M |
| Q1 2026 | May 12, 2026 | −$0.18 | −$0.21 | -14.19% | $18.6M | $19.1M |
| Q4 2025 | Mar 24, 2026 | −$0.18 | −$0.17 | 4.49% | $21.0M | $20.9M |
| Q3 2025 | Nov 13, 2025 | −$0.19 | −$0.19 | 1.50% | $21.8M | $20.7M |
| Q2 2025 | Aug 11, 2025 | −$0.18 | −$0.22 | -25.00% | $20.7M | $20.2M |
| Q1 2025 | May 8, 2025 | −$0.20 | −$0.25 | -27.55% | $17.4M | $18.5M |
| Q4 2024 | Mar 20, 2025 | −$0.21 | −$0.23 | -8.29% | $23.2M | $17.6M |
| Q3 2024 | Nov 7, 2024 | −$0.40 | −$0.42 | -3.78% | $18.8M | $19.0M |
| Q2 2024 | Aug 12, 2024 | −$0.46 | −$0.51 | -11.70% | $18.4M | $16.1M |
| Q1 2024 | May 9, 2024 | −$0.49 | −$0.23 | 52.95% | $16.3M | $16.6M |
| Q4 2023 | Mar 21, 2024 | −$0.45 | −$0.53 | -18.91% | $16.5M | $17.0M |
| Q3 2023 | Nov 9, 2023 | −$0.48 | −$0.45 | 6.43% | $16.2M | $15.1M |
| Q2 2023 | Aug 9, 2023 | −$0.52 | −$0.46 | 11.89% | $14.4M | $14.5M |
| Q1 2023 | May 11, 2023 | −$0.55 | −$0.63 | -15.15% | $12.0M | $11.9M |
| Q4 2022 | Mar 21, 2023 | −$0.53 | −$0.52 | 2.42% | $13.2M | $11.6M |
| Q3 2022 | Nov 9, 2022 | −$0.60 | −$0.64 | -7.20% | $10.9M | $11.2M |
| Q2 2022 | Aug 10, 2022 | −$0.60 | −$0.88 | -45.57% | $10.1M | $10.4M |
| Q1 2022 | May 10, 2022 | −$0.54 | −$0.75 | -38.89% | $7.9M | $8.2M |
| Q4 2021 | Mar 21, 2022 | −$0.52 | −$0.59 | -13.11% | $8.0M | $8.4M |
| Q3 2021 | Nov 10, 2021 | −$0.52 | −$0.57 | -9.97% | $7.6M | $7.7M |

## Frequently Asked Questions

### When did TELA Bio (TELA) last report earnings?

TELA Bio last reported on Aug 10, 2026, covering fiscal Q2 2026.

### Did TELA beat earnings estimates?

No. TELA Bio reported EPS of −$0.20 for Q2 2026 against a −$0.17 estimate — a 15.14% miss.

### How much revenue did TELA report last quarter?

TELA Bio reported $19.3M in revenue for Q2 2026, against a consensus estimate of $20.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).